MOREPEN LABORATORIES
Back to Income Statement
|
MOREPEN LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹118 Cr | ₹96 Cr | ₹39 Cr | ₹102 Cr | ₹97 Cr |
What is the latest Consolidated Net Profit of MOREPEN LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹118 Cr |
| Mar2024 | ₹96 Cr |
| Mar2023 | ₹39 Cr |
| Mar2022 | ₹102 Cr |
| Mar2021 | ₹97 Cr |
How is Consolidated Net Profit of MOREPEN LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹118 Cr | 22.73 | |
| Mar2024 | ₹96 Cr | 148.64 | |
| Mar2023 | ₹39 Cr | -61.97 | |
| Mar2022 | ₹102 Cr | 4.73 | |
| Mar2021 | ₹97 Cr | - | |
Compare Consolidated Net Profit of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹2,363.5 Cr | -5.7% | -12.2% | -42% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,370.0 Cr | 1.2% | 5.5% | 0.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,802.0 Cr | -1.8% | -3.1% | 8.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,841.0 Cr | -2% | 2.8% | 19.2% | Stock Analytics | |
| CIPLA | ₹121,481.0 Cr | -0.7% | -8.6% | 2.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,220.0 Cr | -1.5% | -4.3% | 2.5% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -5.7% |
-12.2% |
-42% |
| SENSEX | -0.1% |
0.6% |
9.8% |
You may also like the below Video Courses